Ray Kurzweil

Sits on 1 board. Last updated September 27, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.

3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 9, 2026 United Therapeutics Corporation Option exercise +650 โ€” โ€”
Mar 4, 2026 United Therapeutics Corporation Option exercise +4,910 $101.80 $499,838
Mar 4, 2026 United Therapeutics Corporation Open-market sale โˆ’4,910 $489.02 $2,401,088
Jul 25, 2025 United Therapeutics Corporation Option exercise +590 โ€” โ€”
Feb 28, 2025 United Therapeutics Corporation Option exercise +15,000 $175.43 $2,631,450
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’2,259 $314.25 $709,891
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’4,821 $315.26 $1,519,868
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’2,256 $316.07 $713,054
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’897 $317.33 $284,645
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’1,303 $318.28 $414,719
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’1,519 $320.43 $486,733
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’1,095 $321.53 $352,075
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’750 $322.43 $241,823
Feb 28, 2025 United Therapeutics Corporation Open-market sale โˆ’100 $323.53 $32,353
Jul 13, 2024 United Therapeutics Corporation Option exercise +900 โ€” โ€”

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.